Friday, October 24, 2025

Latest

Legal Hurdles Remain for Cannabis Companies Seeking NYSE, Nasdaq Listings

Despite the excitement surrounding the potential rescheduling, legal experts caution that it may not be sufficient to open up the NYSE or Nasdaq to cannabis stocks. 

Currently, most American-based cannabis companies are limited to trading on the Over-the-Counter (OTC) markets due to the federal illegality of cannabis, while the majority have turned to Canadian exchanges, such as the Canadian Securities Exchange (CSE) for listing. 

This is where the Drug Enforcement Administration’s (DEA) sign off becomes important as ​​even under Schedule III, cannabis companies would still be violating the Controlled Substances Act by selling a controlled substance without the required DEA registrations.

“Instead of selling an illegal controlled substance illegally, they will be selling a legal controlled substance illegally. And the problem is that none (of those products) will have the required DEA registrations,” Eric Berlin, a partner at the legal firm Dentons explained to Green Market Report

“And the DEA has said that it does not intend to give any registrations or to register any party that is simultaneously violating federal law.”

The stock exchanges have not commented on whether they would allow cannabis stock listings upon rescheduling. Nasdaq’s published rules and regulations suggest that many US cannabis operators would remain ineligible for listing due to their involvement in federally illegal operations.

Nevertheless, investors have reacted positively to the news, with the AdvisorShares Pure US Cannabis ETF experiencing a significant increase in interest following the announcement. 

While the potential tax benefits for cannabis companies under Schedule III are substantial, the path to uplisting on major US stock exchanges – where cheaper capital sits – appears to be further from reach, likely requiring further congressional action.


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Earl Blumenauer Wants Answers On Cannabis Scheduling Review From The DEA

Representative Earl Blumenauer, a Democrat from Oregon, has once again reached out to the Drug...

Saturday, February 10, 2024, 01:39:00 PM

DEA Administrator Reportedly Didn’t Sign Cannabis Rescheduling Order, But Is It Necessary?

Recent developments regarding the signing of a marijuana rescheduling order have sparked debate and speculation...

Wednesday, May 8, 2024, 12:32:39 PM

Acting DEA Chief Says Cannabis Review Is Not Dead—Yet—as Successor Looms

Trump nominee Cole's anti-cannabis stance could alter course...
Wednesday, February 12, 2025, 12:47:00 PM

Is the DEA’s Cannabis Rescheduling Happening with the Delta-8 Final Action?

The Drug Enforcement Administration (DEA) is expected to propose new rules clarifying that manufactured cannabinoids...

Tuesday, April 23, 2024, 03:49:00 PM

DEA’s Hearing Strategy Suggests Reluctance To Cannabis Rescheduling

The U.S. Drug Enforcement Administration appears to be signaling resistance to the growing federal momentum...

Sunday, December 1, 2024, 07:41:00 AM